US Pharma MarketingThe post Sumitomo treats first patient in Phase I/IIa trial of DSP-3077 appeared first on Clinical Trials Arena.
Sumitomo treats first patient in Phase I/IIa trial of DSP-3077
Sumitomo Pharma America has treated the first patient in its Phase I/IIa trial of DSP-3077 for adults with non-syndromic retinitis pigmentosa (RP). The post Sumitomo treats first patient in Phase I/IIa trial of DSP-3077 appeared first on Clinical Trials Arena .
Sumitomo Pharma America has treated the first patient in its Phase I/IIa trial of DSP-3077 for adults with non-syndromic retinitis pigmentosa (RP).
Source: Clinical Trials Arena